| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/06/2011 | EP2340046A2 Polymer conjugates of ziconotide peptides |
| 07/06/2011 | EP2340044A1 Pegylated opioids with low potential for abuse |
| 07/06/2011 | EP2340040A2 Modulation of axon degeneration |
| 07/06/2011 | EP2340026A1 A deproteinised calf blood preparation for use in prevention or treatment of diabetic peripheral polyneuropathy |
| 07/06/2011 | EP2340024A1 Use of 3,11b-cis-dihydrobenazine in the treatment of dementia and associated cognitive deficit |
| 07/06/2011 | EP2066663B1 Heterocyclic fxr binding compounds |
| 07/06/2011 | EP1853576B1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 07/06/2011 | EP1492765B1 Novel gamma secretase inhibitors |
| 07/06/2011 | EP1434588B1 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | EP0707478B1 Improved nicotine lozenge |
| 07/06/2011 | CN1993338B Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 07/06/2011 | CN1903223B Antineoplastic medicine preparation and prepn. method therefor |
| 07/06/2011 | CN1882541B derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/06/2011 | CN1867554B Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors |
| 07/06/2011 | CN1867549B Cyclopropyl derivatives as NK3 receptor antagonists |
| 07/06/2011 | CN102119161A Sulfur-containing heterocyclic derivative having ss-secretase-inhibiting activity |
| 07/06/2011 | CN102119155A Process for the preparation of nicotine-based haptens |
| 07/06/2011 | CN102119142A Salicylamide derivatives as nicotinic alpha 7 modulators |
| 07/06/2011 | CN102119034A Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 07/06/2011 | CN102119028A Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 07/06/2011 | CN102115429A (E)-1-(3,5-dimethoxyphenyl)-2-(3,5-dihydroxy-4-methoxyphenyl)ethylene, and preparation method and application thereof |
| 07/06/2011 | CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof |
| 07/06/2011 | CN102114244A Compositions and methods for treating cognitive disorders |
| 07/06/2011 | CN102114229A Traditional Chinese medicine preparation for treating schizophrenia |
| 07/06/2011 | CN102114214A Chinese medicine for treating diabetic foot |
| 07/06/2011 | CN102114195A Anti-drug capsule prepared from pure traditional Chinese medicines |
| 07/06/2011 | CN102114188A Enema Chinese medicine for treating hepatic encephalopathy in prodromal period |
| 07/06/2011 | CN102114160A Chinese medicine oral decoction for treating headache |
| 07/06/2011 | CN102114149A Chinese medicine preparation for treating epilepsy |
| 07/06/2011 | CN102114144A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 07/06/2011 | CN102114143A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 07/06/2011 | CN102114117A Traditional Chinese medicine for treating schizophrenia |
| 07/06/2011 | CN102114063A Method for extracting and separating asiaticoside by countercurrent extraction combined with membrane separation |
| 07/06/2011 | CN102114060A Amur valeriana extract and preparation method and applications thereof |
| 07/06/2011 | CN102114033A Fragrant preparation for preventing sleepiness and preparation method thereof |
| 07/06/2011 | CN102114024A Compound Cigu capsules for preventing migraine in menstrual period |
| 07/06/2011 | CN102114016A Preparation method of physostigmine derivatives with resistance to activity of senile dementia disease |
| 07/06/2011 | CN102114014A Pharmaceutical composition containing almotriptan |
| 07/06/2011 | CN102114009A Pharmaceutical composition containing tomoxetine and preparation method thereof |
| 07/06/2011 | CN102114002A Enhanced immediate release formulations of topiramate |
| 07/06/2011 | CN101856483B Chinese medicinal composition for treating intermenstrual abnormal emotion and preparation method thereof |
| 07/06/2011 | CN101837080B Topical ointment externally used for treating cervical spondylosis |
| 07/06/2011 | CN101711849B Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method |
| 07/06/2011 | CN101703744B Chinese medicinal composition for treating palpitation and shortness of breath and preparation method thereof |
| 07/06/2011 | CN101700373B Traditional Chinese medicine used for smoking cessation |
| 07/06/2011 | CN101693010B Cefathiamidine prosoma liposome preparation |
| 07/06/2011 | CN101623404B Traditional Chinese medicine composition for treating primary trigeminal neuralgia |
| 07/06/2011 | CN101555476B Small interfering RNA, screening method and application in preparing medicament for treating neuropathic pains |
| 07/06/2011 | CN101538270B 8-alkyl galanthamine salt and preparation method and applications thereof |
| 07/06/2011 | CN101474385B Method for preparing Chinese medicine for treating children's summer-wet type common cold |
| 07/06/2011 | CN101443312B 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions |
| 07/06/2011 | CN101357915B Diazabicyclic central nervous system active agents |
| 07/06/2011 | CN101243089B Halogenated pyrazolo [1,5-A]pyrimidines, processes, uses as GABA-A receptors ligand, compositions and intermediates |
| 07/06/2011 | CN101198614B Thienopyrimidine derivative |
| 07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
| 07/06/2011 | CN101048408B Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 07/05/2011 | US7973165 Imidazole derivatives |
| 07/05/2011 | US7973159 Non-basic melanin concentrating hormone receptor-1 antagonists |
| 07/05/2011 | US7973077 Amino acid based compositions for the treatment of pathological conditions distinguised by insufficient mitochondrial function |
| 07/05/2011 | US7973068 Comprises alpha-adrenergic receptor agonist such as clonidine; side effect inhibition |
| 07/05/2011 | US7973064 Administering to a mammal therapeutically effective amount of opiate analgesic and endothelin antagonist for therapy and prophylaxis of pain |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | CA2649844C Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression |
| 07/05/2011 | CA2630269C Inhibitors of diacyglycerol acyltransferase (dgat) |
| 07/05/2011 | CA2601098C Dipyrazoles as central nervous system agents |
| 07/05/2011 | CA2555064C A pharmaceutical composition |
| 07/05/2011 | CA2506242C 4-tetrazolyl-4phenylpiperidine derivatives for treating pain |
| 07/05/2011 | CA2503884C Cyclic sulfamides for inhibition of gamma-secretase |
| 07/05/2011 | CA2496194C Phenyl-substituted pyrazolopyrimidines |
| 07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
| 07/05/2011 | CA2483228C Carboxamides |
| 07/05/2011 | CA2483205C Hyperforin derivatives, the use thereof and formulations containing them |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2448025C Use of cox-2 inhibitors for the treatment of schizophrenia, delusional disorders, affective disorders, autism or tic disorders |
| 07/05/2011 | CA2444724C Method for differentiating mesenchymal stem cells into neural cells |
| 07/05/2011 | CA2423279C Phthalazinone derivatives |
| 07/05/2011 | CA2421042C The use of tiagabine for treatment of diabetic neuropathy and migraine |
| 07/05/2011 | CA2398772C Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/30/2011 | WO2011079213A2 Treating critically ill patients with intravenous ibuprofen |
| 06/30/2011 | WO2011079119A1 Formulation comprising 1 h - quinazoline - 2, 4 - dione ampa receptor antagonists, in the form of immediate release tablets and preparation thereof |
| 06/30/2011 | WO2011079118A1 Pteridinones as inhibitors of polo-like kinase |
| 06/30/2011 | WO2011079114A1 Pteridinones as inhibitors of polo - like kinase |
| 06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
| 06/30/2011 | WO2011078652A1 Orthosiphon stamineus extracts with beneficial use as cognition enhancer |
| 06/30/2011 | WO2011078479A2 A composition comprising the extract of prunella vulgaris l. for preventing and treating adhd disease and the use thereof |
| 06/30/2011 | WO2011078369A1 Novel aryl urea derivative |
| 06/30/2011 | WO2011078360A1 Amide compound |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011077800A1 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages |
| 06/30/2011 | WO2011077761A1 Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-,(3s,6s)- |
| 06/30/2011 | WO2011077760A1 Learning motivation improvers |
| 06/30/2011 | WO2011077759A1 Extracts and beverages containing 2, 5-piperazinedione, 3, 6-bis (phenylmethyl) -, (3s, 6s) - |
| 06/30/2011 | WO2011077726A1 4-amino-1,3-thiazine or oxazine derivative |
| 06/30/2011 | WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same |
| 06/30/2011 | WO2011077063A1 Use of polysaccharides for treating stress and anxiety |
| 06/30/2011 | WO2011076946A2 Methods and compositions for the treatment of alzheimer |